22.36
Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten
Using data tools to time your Castle Biosciences Inc. exitWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com
How high can Castle Biosciences Inc. stock go2025 Retail Activity & Verified Entry Point Signals - newser.com
Is Castle Biosciences Inc. stock attractive for income investorsJuly 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - newser.com
Castle Biosciences to Release Third Quarter 2025 Financial - GlobeNewswire
Will Castle Biosciences Inc. stock remain a Wall Street favoriteWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Risk adjusted return profile for Castle Biosciences Inc. analyzedGDP Growth & Weekly Market Pulse Alerts - newser.com
When is the best time to exit Castle Biosciences Inc.Quarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
Castle Biosciences, Inc. to Announce Third Quarter 2025 Financial Results on November 3 - Quiver Quantitative
Nov. 3 webcast: Castle Biosciences to release Q3 results and host conference call at 4:30 PM ET - Stock Titan
Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025 - Sahm
New Data Demonstrates Significant & Risk-Appropriate Clinical Impact of DecisionDx-SCC Test Results on Patient Management Dec... - ADVFN
Is Castle Biosciences Inc. stock poised for growthDividend Hike & Proven Capital Preservation Tips - newser.com
Is this a good reentry point in Castle Biosciences Inc.July 2025 PostEarnings & Consistent Return Investment Signals - newser.com
What drives Castle Biosciences Inc stock priceCup and Handle Formations & Free Expert Stock Watchlists - earlytimes.in
How to integrate Castle Biosciences Inc. into portfolio analysis toolsMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for Castle Biosciences (NASDAQ:CSTL) - MarketBeat
Castle Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Castle Biosciences CEO Maetzold sells $30,234 in shares - Investing.com
Will Castle Biosciences Inc. stock pay special dividendsGDP Growth & Weekly Top Gainers Trade List - newser.com
How Castle Biosciences Inc. stock reacts to Fed rate cuts2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Order flow analysis tools used on Castle Biosciences Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com
Analyzing net buyer seller activity in Castle Biosciences Inc.Trade Volume Summary & Verified Technical Trade Signals - newser.com
Is Castle Biosciences Inc a good long term investmentBollinger Bands Signals & Low Risk Investment Growth - earlytimes.in
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine - The Manila Times
Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire
Selected from 586 Executives: Castle Biosciences' Derek Maetzold Crowned CEO of the Year 2025 - Stock Titan
User - FinancialContent
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What analysts say about Castle Biosciences Inc stockSmall Cap Stock Opportunities & High Profit Market Tips - Early Times
Strs Ohio Takes $366,000 Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award - markets.businessinsider.com
SciBase Receives Initial Order for Clinical Study From Castle Biosciences - 富途牛牛
Castle Biosciences (NASDAQ:CSTL) Insider Sells $29,417.83 in Stock - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):